AXIN1 and colonic neoplasm: Notably, it was able to promote β-catenin degradation in SNU475 hepatoma cells, which carry an axin mutation, as well as in SW480 colon cancer cells with APC mutation, and suppressed the growth of CRT-positive cancer cells.